Barclays
BNTX icon

Barclays’s BioNTech BNTX Stock Holding History

Barclays’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,000
Closed -$3.19M – 5494
2025
Q2 		$3.19M Buy
30,000
+7,500
+33% +$758K ﹤0.01% 2496
2025
Q1 		$2.05M Hold
22,500
– – ﹤0.01% 2609
2024
Q4 		$2.56M Buy
+22,500
New +$2.57M ﹤0.01% 2702
2023
Q1 		– Sell
-36,900
Closed -$5.54M – 5104
2022
Q4 		$5.54M Buy
+36,900
New +$5.68M ﹤0.01% 1549

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays's BNTX Position: Q1 2026 in Review

Barclays reduced its BioNTech (BNTX) stake by 12% in Q1 2026, selling an estimated $2.12M and leaving 152,473 shares worth $13.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Barclays first reported a position in BNTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $26.1M in Q1 2022. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Barclays held 152,473 shares of BioNTech worth $13.6M as of Q1 2026.
  • Barclays sold 20,616 BioNTech shares in Q1 2026, an estimated $2.12M.
  • BioNTech made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1286 holding.
  • Barclays first reported a position in BioNTech in Q1 2022 and has held it in 17 quarters since.
  • Barclays's BioNTech position peaked at $26.1M in Q1 2022.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.